These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4766785)

  • 1. [Production and control in pharmaceutical industry. Quality control and guarantee of quality. Requirements of IKS-rules in the quality control].
    Sahli M; Bircher M
    Pharm Acta Helv; 1973; 48(8):429-42. PubMed ID: 4766785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines].
    Zinn W
    Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in middle-sized plants].
    Schlumpf R
    Pharm Acta Helv; 1973; 48(8):471-81. PubMed ID: 4766788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in bigger plants].
    Forster O
    Pharm Acta Helv; 1973; 48(8):455-70. PubMed ID: 4766787
    [No Abstract]   [Full Text] [Related]  

  • 6. [Elaboration of examination rules for initial substances and end products].
    Hubmann E
    Pharm Acta Helv; 1973; 48(8):443-54. PubMed ID: 4766786
    [No Abstract]   [Full Text] [Related]  

  • 7. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in middle size plants].
    Bucher K
    Pharm Acta Helv; 1973 Feb; 48(2):101-16. PubMed ID: 4706308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quality control in the pharmaceutical industry].
    Bretscher E
    Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535
    [No Abstract]   [Full Text] [Related]  

  • 9. [Standards of good production. Problems of sampling].
    Fontani F; Sekules G; Zanotti Gerosa A
    Boll Chim Farm; 1975 Feb; 114(2):57-69. PubMed ID: 1203102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants].
    Schlumpf R
    Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality engineering 1978.
    Waldner JW
    J Parenter Drug Assoc; 1978; 32(5):205-8. PubMed ID: 251196
    [No Abstract]   [Full Text] [Related]  

  • 13. [Standards of good production. Human and technical aspects].
    Rocchi B
    Boll Chim Farm; 1975 Jan; 114(1):3-9. PubMed ID: 1203097
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quality control changes in release controller system].
    Smewing J
    Boll Chim Farm; 2001; 140(3):192-4. PubMed ID: 11486613
    [No Abstract]   [Full Text] [Related]  

  • 15. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 16. A new approach to quality training.
    Betts WA
    J Parenter Sci Technol; 1981; 35(5):248-50. PubMed ID: 7299602
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality: an old solution to new discovery dilemmas?
    Volsen SG; Kent JM; Masson M
    Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 19. Expectations for process validation: industry perspectives.
    Francis R
    Dev Biol (Basel); 2003; 113():9-14. PubMed ID: 14620847
    [No Abstract]   [Full Text] [Related]  

  • 20. Developing a formal training program for a small to medium sized pharmaceutical company.
    Kapoor J; Murthy BS; Franklin G
    Bull Parenter Drug Assoc; 1977; 31(1):52-6. PubMed ID: 831900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.